James Hoon Rhee, MD
Physical Medicine and Rehabilitation · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 3
- Since medical school
- 35 years
- Loyola University of Chicago, Stritch School of Medicine, 1991
Offices
3 locations · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Adventist Health Sonora · John Muir Medical Center - Walnut Creek Campus · Stanford Health Care · Stanford Health Care Tri-Valley · Sutter Tracy Community Hospital. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rhee’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G85069 · Current
Licensed to practise in California · since 1999 · expires 2028-06-30 · Loyola University of Chicago Stritch School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Tracy Surgery Center, LLC DBA Tracy Surgery CenterAmbulatory Surgery Center · Tracy, CA1% owner since 2015 · accredited by AAAHCAccreditation Renewed3 inspections, 1 with deficiencies · last 2023-06-28: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Physical Medicine and Rehabilitation - Physical Medicine and Rehabilitation
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health SonoraSonora, CAAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 64% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Postoperative wound dehiscence rate: 3.5 (2.04 to 4.96) · 288 cases, Jul 2022 – Jun 2024Worse than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 1.3 (1 to 1.6) · 1,004 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.185, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
- Sutter Tracy Community HospitalTracy, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Sonora
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative wound dehiscence rateComplications and deaths | 3.5 (2.04 to 4.96) · 288 cases | Worse | Jul 2022 – Jun 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (1 to 1.6) · 1,004 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.185 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.15 (0.14 to 2.16) · 582 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.5 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 182.91 (123.44 to 242.37) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9 · 125 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.7 · 236 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15 · 433 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12 · 72 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,364 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.39) · 3,671 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,602 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.24 to 5.59) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.57 (0 to 3.24) · 310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.98 to 4.2) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.97 (0 to 16.16) · 306 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.72 (1.85 to 9.58) · 277 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 1.06) · 2,750 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.614 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 209 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 12.6 · 119 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -23.8 · 255 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -13.4 · 455 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 381 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4.3 to 8.1) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (9.1 to 14.7) · 328 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.3) · 1,835 cases | No different | Jan 2022 – Dec 2024 |
What patients said (326 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 64% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Tracy Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 2 better, 5 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.21 to 2.34) · 363 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 156 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.6 · 51 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 835 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,800 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,820 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.09 (0.6 to 5.57) · 291 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 138 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 274 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (0 to 17.04) · 145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.93 (0.72 to 9.15) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 26 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.981 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.8 · 194 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -47.9 · 145 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.1 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.3 to 16.7) · 504 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 104 cases | No different | Jan 2024 – Dec 2024 |
What patients said (443 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$205,756
Medicare paid this office $205,756 for 956 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 360 | $52,125 | $145 |
| Return visit (30+ min) | 271 | $37,554 | $113 |
| Short return visit (20+ min) | 280 | $33,105 | $80 |
| New patient visit (30+ min) | 198 | $19,360 | $98 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 32 | $12,377 | None |
See all 19 services
| New patient visit (45+ min) | 360 | $52,125 | $145 |
| Return visit (30+ min) | 271 | $37,554 | $113 |
| Short return visit (20+ min) | 280 | $33,105 | $80 |
| New patient visit (30+ min) | 198 | $19,360 | $98 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 32 | $12,377 | None |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 84 | $10,500 | $100 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 54 | $6,642 | $113 |
| Short return visit | 71 | $4,399 | $54 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 143 | $3,131 | $15 |
| Nerve test | 29 | $3,129 | $101 |
| Injection of substance into lower spine canal using imaging guidance | 31 | $2,923 | $81 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 13 | $2,638 | $203 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 15 | $2,435 | $111 |
| Muscle electrical test | 12 | $1,217 | $87 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 19 | $908 | $43 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $632 | $49 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | $181 | None |
| Injection, methylprednisolone acetate, 1 mg | 16 | $136 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $125 | $10 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 28 | 46 | 80 | 99 | 106 | 59 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | – | – | 31 | 37 | 90 | 105 |
| Injection of substance into lower spine canal using imaging guidance | 26 | – | 35 | 28 | 25 | 36 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | – | 18 | 19 | 40 | 45 | 22 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 13 | 15 | 32 | 25 | 27 | 21 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | – | 12 | 15 | 27 | 22 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
956 Original Medicare patients in 2024. Average age 75 · Under 65 4% · 85 and older 13% · Women 59% · Also on Medicaid 13% · Health risk score 1.08. At or below the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 1.53.
Conditions among them: High blood pressure 73% · Chronic kidney disease 28% · Diabetes 24% · Coronary heart disease 22% · Depression 18% · Cancer 17% · Atrial fibrillation 16% · COPD 14% · Heart failure 12% · Stroke 6% · Dementia 5%.
The office billed $2,072,581, Medicare allowed $277,413 and paid $205,756; for 6,131 services of 44 kinds; $13,119 of it was for drugs given in the office and $192,637 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 956 | 6,131 | 75 | 1.08 | $2,072,581 | $205,756 |
| 2023 | 846 | 3,645 | 75 | 1.18 | $2,223,559 | $203,716 |
| 2022 | 604 | 2,321 | 75 | 1.13 | $1,708,705 | $148,628 |
| 2021 | 519 | 1,563 | 74 | 1.10 | $1,002,992 | $111,327 |
| 2020 | 301 | 1,313 | 73 | 1.18 | $737,811 | $74,974 |
| 2019 | 209 | 694 | 74 | 1.06 | $226,374 | $43,962 |
| 2018 | 426 | 1,811 | 73 | 1.09 | $369,896 | $120,067 |
| 2017 | 332 | 1,095 | 72 | 1.10 | $254,010 | $85,611 |
| 2016 | 228 | 1,122 | 72 | 1.16 | $213,842 | $68,338 |
| 2015 | 254 | 1,342 | 73 | 1.13 | $247,731 | $80,273 |
| 2014 | 241 | 1,307 | 73 | 1.06 | $258,561 | $81,055 |
| 2013 | 203 | 1,069 | 73 | 1.04 | $202,134 | $66,276 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| New patient visit (45+ min) | 354 | $50,847 | $144 |
| Short return visit (20+ min) | 271 | $34,387 | $82 |
| Return visit (30+ min) | 188 | $29,239 | $117 |
| New patient visit (30+ min) | 139 | $12,657 | $91 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 95 | $12,274 | $116 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 76 | $9,180 | $102 |
| Short return visit | 102 | $6,093 | $51 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 23 | $5,677 | $247 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 14 | $5,107 | None |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 36 | $4,947 | $110 |
| Nerve test | 27 | $2,977 | $110 |
| Telehealth originating site facility fee | 93 | $2,582 | $21 |
| Muscle electrical test | 20 | $2,113 | $88 |
| Injection of substance into lower spine canal using imaging guidance | 24 | $2,017 | $81 |
| Nerve test | 11 | $1,946 | $177 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 26 | $1,344 | $50 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 18 | $1,333 | $61 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 16 | $1,193 | $75 |
| New patient visit (15+ min) | 27 | $1,092 | $40 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 56 | $295 | $5 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $228 | None |
2022: 20 services
| New patient visit (45+ min) | 204 | $30,382 | $149 |
| Short return visit (20+ min) | 177 | $21,980 | $81 |
| Return visit (30+ min) | 140 | $21,035 | $117 |
| New patient visit (30+ min) | 147 | $14,078 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 90 | $11,399 | $115 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 25 | $6,397 | $246 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 39 | $4,489 | $112 |
| Short return visit | 71 | $3,877 | $46 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 32 | $3,674 | $99 |
| Telehealth originating site facility fee | 119 | $3,074 | $19 |
| Muscle electrical test | 21 | $2,294 | $88 |
| Injection of substance into lower spine canal using imaging guidance | 27 | $2,293 | $82 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 26 | $1,662 | $62 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 24 | $1,247 | $50 |
| Nerve test | 12 | $1,210 | $101 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 15 | $1,054 | $70 |
| New patient visit (15+ min) | 21 | $916 | $44 |
| Telephone medical discussion with physician, 5-10 minutes | 13 | $596 | $43 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 62 | $372 | $5 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 32 | $132 | None |
2021: 19 services
| New patient visit (45+ min) | 156 | $21,360 | $137 |
| Short return visit (20+ min) | 143 | $17,712 | $84 |
| New patient visit (30+ min) | 161 | $15,684 | $97 |
| Return visit (30+ min) | 100 | $15,195 | $116 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 73 | $9,112 | $114 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 28 | $3,000 | $97 |
| Injection of substance into lower spine canal using imaging guidance | 34 | $2,718 | $78 |
| Telehealth originating site facility fee | 92 | $2,097 | $21 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 19 | $2,090 | $110 |
| Short return visit | 36 | $2,010 | $53 |
| New patient visit (15+ min) | 44 | $1,944 | $44 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 28 | $1,548 | $48 |
| Muscle electrical test | 30 | $1,524 | $41 |
| Nerve test | 19 | $1,177 | $62 |
| Nerve test | 11 | $1,090 | $99 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 15 | $908 | $61 |
| Nerve test | 11 | $740 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 45 | $544 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 35 | $165 | None |
2020: 13 services
| New patient visit (45+ min) | 115 | $14,032 | $122 |
| Short return visit (20+ min) | 94 | $9,941 | $64 |
| New patient visit (30+ min) | 92 | $8,554 | $93 |
| Return visit (30+ min) | 74 | $8,278 | $83 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 43 | $5,196 | $113 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 12 | $2,954 | $227 |
| Telehealth originating site facility fee | 71 | $2,192 | $21 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 16 | $1,702 | $95 |
| Muscle electrical test | 19 | $1,187 | $41 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $725 | $48 |
| Short return visit | 13 | $674 | $37 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 11 | $650 | $54 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 34 | $430 | $10 |
2019: 8 services
| Return visit (30+ min) | 101 | $11,958 | $87 |
| New patient visit (45+ min) | 49 | $6,480 | $132 |
| Short return visit (20+ min) | 72 | $5,587 | $56 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 24 | $3,194 | $114 |
| Injection of substance into lower spine canal using imaging guidance | 26 | $2,197 | $84 |
| Long return visit (40+ min) | 16 | $1,887 | $118 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 12 | $630 | $48 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $376 | $10 |
2018: 18 services
| Return visit (30+ min) | 211 | $36,460 | $95 |
| Short return visit (20+ min) | 136 | $16,511 | $63 |
| New patient visit (45+ min) | 113 | $15,745 | $139 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 85 | $10,954 | $114 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 16 | $8,244 | $25 |
| Long return visit (40+ min) | 66 | $7,238 | $106 |
| Injection of substance into lower spine canal using imaging guidance | 41 | $3,704 | $88 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 19 | $1,991 | $105 |
| Extended patient service without direct patient contact, first hour | 16 | $1,539 | $96 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 23 | $1,183 | $47 |
| Evaluation for physical therapy, typically 20 minutes | 15 | $1,110 | $74 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 89 | $1,100 | $11 |
| Injection of trigger points, 1-2 muscles | 18 | $993 | $47 |
| Short return visit | 20 | $733 | $35 |
| X-ray of pelvis, 1-2 views | 20 | $598 | $30 |
| X-ray of lower and sacral spine, 2-3 views | 17 | $595 | $33 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 23 | $462 | $11 |
| Injection, methylprednisolone acetate, 40 mg | 22 | $123 | None |
2017: 14 services
| Return visit (30+ min) | 124 | $19,723 | $90 |
| New patient visit (45+ min) | 102 | $14,049 | $138 |
| Short return visit (20+ min) | 99 | $11,270 | $64 |
| Long return visit (40+ min) | 69 | $8,766 | $122 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 47 | $5,443 | $109 |
| Extended patient service without direct patient contact, first hour | 33 | $3,165 | $96 |
| Muscle electrical test | 25 | $2,624 | $85 |
| Injection of substance into lower spine canal using imaging guidance | 33 | $2,533 | $77 |
| New patient visit (60+ min) | 12 | $2,029 | $169 |
| Nerve test | 11 | $1,567 | $142 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 14 | $748 | $47 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 62 | $740 | $11 |
| X-ray of lower and sacral spine, 2-3 views | 15 | $464 | $31 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $77 | None |
2016: 13 services
| Return visit (30+ min) | 94 | $14,575 | $87 |
| New patient visit (45+ min) | 59 | $7,267 | $123 |
| Short return visit (20+ min) | 62 | $6,530 | $60 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 16 | $5,263 | $28 |
| Long return visit (40+ min) | 35 | $5,048 | $120 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 32 | $3,598 | $106 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 12 | $3,480 | $24 |
| Muscle electrical test | 29 | $2,683 | $81 |
| Injections of substances into lower or sacral spine | 25 | $1,959 | $73 |
| Nerve test | 13 | $1,709 | $131 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 37 | $1,431 | $35 |
| Muscle electrical test | 16 | $1,076 | $67 |
| Muscle electrical test | 15 | $1,017 | $17 |
2015: 16 services
| Return visit (30+ min) | 103 | $20,208 | $91 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 35 | $10,929 | $28 |
| New patient visit (45+ min) | 52 | $7,379 | $142 |
| Short return visit (20+ min) | 59 | $5,124 | $60 |
| Long return visit (40+ min) | 28 | $3,998 | $125 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 25 | $2,965 | $114 |
| Muscle electrical test | 32 | $2,942 | $82 |
| Injections of substances into lower or sacral spine | 36 | $2,885 | $76 |
| New patient visit (60+ min) | 14 | $2,494 | $178 |
| Muscle electrical test | 33 | $2,386 | $72 |
| Muscle electrical test | 33 | $2,267 | $17 |
| Nerve test | 18 | $2,243 | $125 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 44 | $1,777 | $35 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 13 | $1,270 | $85 |
| Short return visit | 15 | $554 | $37 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $258 | $18 |
2014: 17 services
| Return visit (30+ min) | 92 | $15,998 | $88 |
| New patient visit (45+ min) | 52 | $6,803 | $131 |
| Long return visit (40+ min) | 45 | $6,389 | $121 |
| Short return visit (20+ min) | 62 | $5,801 | $61 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 25 | $5,265 | $25 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 34 | $4,205 | $114 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 11 | $3,121 | $25 |
| New patient visit (60+ min) | 14 | $2,464 | $176 |
| Muscle electrical test | 22 | $2,392 | $82 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 49 | $1,982 | $35 |
| Muscle electrical test | 25 | $1,817 | $73 |
| Muscle electrical test | 24 | $1,681 | $18 |
| Injections of substances into lower or sacral spine | 24 | $1,416 | $57 |
| Fluoroscopic guidance for spine or back muscle injection | 42 | $1,132 | $26 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 11 | $1,112 | $93 |
| New patient visit (30+ min) | 11 | $1,033 | $94 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $377 | $34 |
2013: 13 services
| Return visit (30+ min) | 89 | $15,010 | $87 |
| New patient visit (45+ min) | 45 | $6,240 | $139 |
| Short return visit (20+ min) | 57 | $5,328 | $60 |
| Long return visit (40+ min) | 33 | $4,680 | $123 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 27 | $3,339 | $115 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 18 | $2,759 | $21 |
| New patient visit (60+ min) | 14 | $2,253 | $161 |
| Injections of substances into lower or sacral spine | 23 | $2,079 | $72 |
| Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes | 44 | $1,933 | $36 |
| Muscle electrical test | 18 | $1,510 | $79 |
| Muscle electrical test | 18 | $1,281 | $71 |
| Fluoroscopic guidance for spine or back muscle injection | 30 | $940 | $25 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $415 | $35 |
Drugs they prescribed that Part D paid
$8,237
Pharmacies billed $8,237 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 15% of their Part D prescriptions (92 of 599) in 2024. Above the middle of the specialty; the typical physical medicine and rehabilitation clinician is at 12%.
597 generic and fewer than 11 brand-name prescriptions · $8,237 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 40 | $1,742 | $44 |
| Gabapentin | 119 | $1,198 | $10 |
| Etodolac | 39 | $913 | $23 |
| Calcitonin-Salmon | 11 | $857 | $78 |
| Pregabalin | 22 | $484 | $22 |
See all 15 drugs
| Celecoxib | 40 | $1,742 | $44 |
| Gabapentin | 119 | $1,198 | $10 |
| Etodolac | 39 | $913 | $23 |
| Calcitonin-Salmon | 11 | $857 | $78 |
| Pregabalin | 22 | $484 | $22 |
| Methylprednisolone | 67 | $462 | $7 |
| Hydrocodone-Acetaminophen | 61 | $446 | $7 |
| Duloxetine | 14 | $385 | $27 |
| Meloxicam | 75 | $347 | $5 |
| Cyclobenzaprine | 20 | $296 | $15 |
| Methocarbamol | 21 | $240 | $11 |
| Ibuprofen | 14 | $164 | $12 |
| Diclofenac | 14 | $108 | $8 |
| Oxycodone-Acetaminophen | 12 | $82 | $7 |
| Lorazepam | 30 | $38 | $1 |
Year by year
| 2024 | 599 | 254 | 15% (92) | None | $8,237 |
| 2023 | 609 | 215 | 15% (91) | 0% | $9,267 |
| 2022 | 390 | 141 | 16% (62) | 0% | $6,864 |
| 2021 | 312 | 117 | 17% (54) | None | $5,825 |
| 2020 | 246 | 94 | 24% (60) | None | $4,208 |
| 2019 | 461 | 106 | 29% (135) | 5% | $23,361 |
| 2018 | 1,058 | 168 | 39% (411) | 5% | $53,006 |
| 2017 | 716 | 124 | 37% (268) | 7% | $44,798 |
| 2016 | 504 | 65 | 44% (224) | 7% | $33,730 |
| 2015 | 457 | 68 | 41% (189) | 12% | $34,280 |
| 2014 | 385 | 85 | 45% (173) | 17% | $36,795 |
| 2013 | 333 | 68 | 41% (138) | 19% | $32,124 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 11 drugs
| Gabapentin | 178 | $2,361 | $13 |
| Celecoxib | 33 | $1,550 | $47 |
| Pregabalin | 29 | $1,073 | $37 |
| Meloxicam | 100 | $627 | $6 |
| Hydrocodone-Acetaminophen | 57 | $416 | $7 |
| Methylprednisolone | 42 | $365 | $9 |
| Cyclobenzaprine | 20 | $330 | $17 |
| Methocarbamol | 24 | $259 | $11 |
| Oxycodone-Acetaminophen | 19 | $258 | $14 |
| Ibuprofen | 14 | $205 | $15 |
| Lorazepam | 20 | $22 | $1 |
2022: 8 drugs
| Pregabalin | 29 | $1,892 | $65 |
| Gabapentin | 125 | $1,325 | $11 |
| Cyclobenzaprine | 18 | $724 | $40 |
| Hydrocodone-Acetaminophen | 34 | $312 | $9 |
| Methylprednisolone | 32 | $300 | $9 |
| Meloxicam | 49 | $232 | $5 |
| Methocarbamol | 17 | $223 | $13 |
| Lorazepam | 11 | $13 | $1 |
2021: 11 drugs
| Pregabalin | 18 | $1,036 | $58 |
| Calcitonin-Salmon | 14 | $820 | $59 |
| Celecoxib | 17 | $802 | $47 |
| Gabapentin | 79 | $735 | $9 |
| Etodolac | 11 | $587 | $53 |
| Methocarbamol | 13 | $315 | $24 |
| Hydrocodone-Acetaminophen | 22 | $182 | $8 |
| Methylprednisolone | 19 | $172 | $9 |
| Meloxicam | 39 | $164 | $4 |
| Cyclobenzaprine | 11 | $139 | $13 |
| Tramadol | 14 | $50 | $4 |
2020: 9 drugs
| Gabapentin | 52 | $731 | $14 |
| Celecoxib | 12 | $628 | $52 |
| Methocarbamol | 14 | $342 | $24 |
| Meloxicam | 29 | $305 | $11 |
| Diclofenac | 15 | $231 | $15 |
| Methylprednisolone | 21 | $230 | $11 |
| Hydrocodone-Acetaminophen | 21 | $179 | $9 |
| Acetaminophen-Codeine | 12 | $81 | $7 |
| Tramadol | 13 | $27 | $2 |
2019: 11 drugs
| Lyrica | 15 | $5,430 | $362 |
| Gabapentin | 110 | $2,670 | $24 |
| Hydrocodone-Acetaminophen | 68 | $1,390 | $20 |
| Oxycodone-Acetaminophen | 23 | $1,184 | $51 |
| Cyclobenzaprine | 34 | $522 | $15 |
| Methocarbamol | 17 | $382 | $22 |
| Meloxicam | 34 | $318 | $9 |
| Diclofenac | 15 | $282 | $19 |
| Tizanidine | 12 | $242 | $20 |
| Methylprednisolone | 18 | $184 | $10 |
| Tramadol | 11 | $113 | $10 |
2018: 24 drugs
| Oxycontin | 12 | $15,754 | $1,313 |
| Lyrica | 27 | $12,455 | $461 |
| Hydrocodone-Acetaminophen | 250 | $6,216 | $25 |
| Gabapentin | 134 | $3,678 | $27 |
| Oxycodone-Acetaminophen | 37 | $1,662 | $45 |
| Cyclobenzaprine | 86 | $1,533 | $18 |
| Etodolac | 29 | $1,500 | $52 |
| Fentanyl | 11 | $1,159 | $105 |
| Oxycodone | 34 | $1,016 | $30 |
| Celecoxib | 17 | $929 | $55 |
| Duloxetine | 17 | $762 | $45 |
| Meloxicam | 83 | $622 | $7 |
| Tizanidine | 34 | $616 | $18 |
| Lidocaine | 11 | $575 | $52 |
| Diclofenac | 23 | $540 | $23 |
| Methylprednisolone | 34 | $410 | $12 |
| Tramadol | 39 | $406 | $10 |
| Methocarbamol | 31 | $391 | $13 |
| Ondansetron | 11 | $200 | $18 |
| Baclofen | 16 | $191 | $12 |
| Hydromorphone | 11 | $177 | $16 |
| Carisoprodol | 17 | $125 | $7 |
| Zolpidem | 12 | $79 | $7 |
| Diazepam | 11 | $70 | $6 |
2017: 23 drugs
| Oxycontin | 23 | $17,980 | $782 |
| Lyrica | 20 | $11,111 | $556 |
| Hydrocodone-Acetaminophen | 111 | $2,009 | $18 |
| Cyclobenzaprine | 49 | $1,465 | $30 |
| Oxycodone-Acetaminophen | 34 | $1,195 | $35 |
| Duloxetine | 12 | $1,135 | $95 |
| Gabapentin | 102 | $1,123 | $11 |
| Tramadol Hcl Er | 12 | $1,085 | $90 |
| Oxycodone | 32 | $929 | $29 |
| Etodolac | 15 | $790 | $53 |
| Celecoxib | 12 | $763 | $64 |
| Diclofenac | 31 | $396 | $13 |
| Tramadol | 24 | $256 | $11 |
| Meloxicam | 39 | $246 | $6 |
| Hydromorphone | 13 | $211 | $16 |
| Naproxen | 14 | $172 | $12 |
| Methylprednisolone | 12 | $141 | $12 |
| Diazepam | 24 | $120 | $5 |
| Zolpidem | 13 | $93 | $7 |
| Methocarbamol | 17 | $83 | $5 |
| Carisoprodol | 11 | $77 | $7 |
| Topiramate | 11 | $33 | $3 |
| Clonidine | 11 | $32 | $3 |
2016: 17 drugs
| Oxycontin | 24 | $16,365 | $682 |
| Hydrocodone-Acetaminophen | 75 | $3,119 | $42 |
| Oxycodone-Acetaminophen | 42 | $2,678 | $64 |
| Oxycodone | 22 | $1,500 | $68 |
| Fentanyl | 15 | $1,122 | $75 |
| Gabapentin | 60 | $1,080 | $18 |
| Etodolac | 23 | $931 | $40 |
| Hydromorphone | 12 | $229 | $19 |
| Naproxen | 13 | $208 | $16 |
| Diazepam | 35 | $205 | $6 |
| Methylprednisolone | 11 | $183 | $17 |
| Cyclobenzaprine | 18 | $131 | $7 |
| Ondansetron | 12 | $86 | $7 |
| Topiramate | 12 | $84 | $7 |
| Tramadol | 16 | $79 | $5 |
| Zolpidem | 11 | $79 | $7 |
| Meloxicam | 13 | $56 | $4 |
2015: 13 drugs
| Oxycontin | 24 | $14,653 | $611 |
| Oxycodone-Acetaminophen | 42 | $3,404 | $81 |
| Hydrocodone-Acetaminophen | 61 | $3,356 | $55 |
| Fentanyl | 21 | $2,038 | $97 |
| Celecoxib | 14 | $1,498 | $107 |
| Etodolac | 22 | $1,096 | $50 |
| Gabapentin | 61 | $835 | $14 |
| Voltaren | 11 | $743 | $68 |
| Methocarbamol | 11 | $347 | $32 |
| Methylprednisolone | 12 | $232 | $19 |
| Diazepam | 32 | $136 | $4 |
| Acetaminophen-Codeine | 13 | $77 | $6 |
| Meloxicam | 19 | $55 | $3 |
2014: 11 drugs
| Oxycontin | 28 | $15,609 | $557 |
| Celebrex | 24 | $6,384 | $266 |
| Oxycodone-Acetaminophen | 29 | $3,248 | $112 |
| Hydrocodone-Acetaminophen | 67 | $2,149 | $32 |
| Fentanyl | 12 | $1,936 | $161 |
| Gabapentin | 38 | $968 | $25 |
| Etodolac | 16 | $577 | $36 |
| Carisoprodol | 16 | $466 | $29 |
| Hydromorphone | 11 | $247 | $22 |
| Diazepam | 24 | $147 | $6 |
| Meloxicam | 15 | $118 | $8 |
2013: 11 drugs
| Oxycontin | 28 | $14,764 | $527 |
| Celebrex | 17 | $2,917 | $172 |
| Fentanyl | 14 | $2,346 | $168 |
| Gabapentin | 41 | $1,574 | $38 |
| Oxycodone Hcl-Acetaminophen | 16 | $1,076 | $67 |
| Hydrocodone-Acetaminophen | 40 | $1,042 | $26 |
| Etodolac | 12 | $394 | $33 |
| Carisoprodol | 18 | $283 | $16 |
| Diclofenac | 13 | $244 | $19 |
| Oxycodone-Acetaminophen | 11 | $157 | $14 |
| Diazepam | 12 | $53 | $4 |
Money from drug and device companies
$114 in 2025
| 2025 | 1 | 1 | None | $114 |
| 2024 | 1 | 7 | None | $1,175 |
| 2022 | 1 | 1 | None | $59 |
| 2020 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Axonics | $114 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2025-01-10 | Axonics | $114 |
See earlier years (2024, 2022, 2020)
2024: $1,175
| Pacira Pharmaceuticals | Iovera | $1,175 | 7 payments
|
2022: $59
| SPR Therapeutics | Sprint Pns System | $59 | 1 payment
|
2020: $16
| Abbott Laboratories | Prodigy Family of Scs Ipgs | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1629074364
- Licence
- CA G85069California G85069: Current · expires 2028-06-30
- Trained
- Loyola University of Chicago, Stritch School of Medicine, 1991 · 35 years ago
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2081P2900X (2081P2900X); Federal specialty code 208100000X (208100000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2005-06-27
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.